The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17.
作者信息
Lyden Patrick, Broderick Joseph, Grotta James, Kwiatkowski Thomas, Levine Steven, Frankel Michael, Haley E Clarke, Tilley Barbara
机构信息
Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute of the Keck School of Medicine at USC, 1501 San Pablo Street, ZNI Room 245, Los Angeles, CA, 90033, USA.
University of Cincinnati Gardner Neuroscience Institute, Cincinnati, OH, USA.
出版信息
BMC Med Res Methodol. 2023 Nov 21;23(1):275. doi: 10.1186/s12874-023-02074-5.
Abstract
摘要
相似文献
1
The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17.临床试验中隐匿与盲法的区别以及二者为何都很重要。对加尔格和米克瑙奇的回复，《BMC医学研究方法》（2022年）第22卷：第17期
BMC Med Res Methodol. 2023 Nov 21;23(1):275. doi: 10.1186/s12874-023-02074-5.
2
Different antibiotic treatments for group A streptococcal pharyngitis.不同的抗生素治疗方案用于治疗 A 组链球菌性咽炎。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD004406. doi: 10.1002/14651858.CD004406.pub6.
3
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
4
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准（CONSORT）以及医学期刊上发表的随机对照试验（RCT）的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
5
Yoga for epilepsy.用于癫痫治疗的瑜伽
Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD001524. doi: 10.1002/14651858.CD001524.pub3.
6
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).辅助生殖（体外受精和卵胞浆内单精子注射）中刺激周期的监测。
Cochrane Database Syst Rev. 2014 Aug 24;2014(8):CD005289. doi: 10.1002/14651858.CD005289.pub3.
7
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.囊性纤维化的增效剂（针对III类和IV类突变的特定疗法）。
Cochrane Database Syst Rev. 2015 Mar 26(3):CD009841. doi: 10.1002/14651858.CD009841.pub2.
8
Discordant Information on Blinding in Trial Registries and Published Research: A Systematic Review.试验注册库与已发表研究中关于盲法的不一致信息：一项系统综述
JAMA Netw Open. 2024 Dec 2;7(12):e2452274. doi: 10.1001/jamanetworkopen.2024.52274.
9
Introducing a novel sham acupuncture method for double-blind trials: A validation study.
Complement Ther Med. 2025 Sep;92:103198. doi: 10.1016/j.ctim.2025.103198. Epub 2025 Jul 4.
10
Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?骨科随机试验中的结果报告：结果评估者的盲法是否重要？
J Bone Joint Surg Am. 2007 Mar;89(3):550-8. doi: 10.2106/JBJS.F.00683.
引用本文的文献
1
Using Radial Shock Wave Therapy to Control Cerebral Palsy-Related Dysfunctions: A Randomized Controlled Trial [Response to Letter].使用径向冲击波疗法控制脑瘫相关功能障碍：一项随机对照试验[对信件的回复]
Int J Gen Med. 2025 May 13;18:2537-2538. doi: 10.2147/IJGM.S538434. eCollection 2025.
本文引用的文献
1
Risk of selection bias assessment in the NINDS rt-PA stroke study.NINDS rt-PA 卒中研究中选择偏倚风险评估。
BMC Med Res Methodol. 2022 Jun 15;22(1):172. doi: 10.1186/s12874-022-01651-4.
2
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.根据定义欧盟和美国上市许可标准的急性脑卒中阿替普酶治疗效果：随机试验的个体患者数据分析荟萃分析。
Int J Stroke. 2018 Feb;13(2):175-189. doi: 10.1177/1747493017744464. Epub 2017 Nov 24.
3
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.阿替普酶治疗急性卒中对功能结局分布的影响：9项试验的汇总分析
Stroke. 2016 Sep;47(9):2373-9. doi: 10.1161/STROKEAHA.116.013644. Epub 2016 Aug 9.
4
Thrombolysis for acute ischaemic stroke.急性缺血性卒中的溶栓治疗
Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD000213. doi: 10.1002/14651858.CD000213.pub3.
5
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.参与“遵循卒中指南”项目的医院中急性缺血性卒中患者的特征及静脉溶栓治疗的时间趋势。
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):543-9. doi: 10.1161/CIRCOUTCOMES.111.000303.
6
Thrombolysis in stroke despite contraindications or warnings?溶栓治疗脑卒中，禁忌证和警告是否需要考虑？
Stroke. 2013 Mar;44(3):727-33. doi: 10.1161/STROKEAHA.112.674622. Epub 2013 Feb 6.
7
Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.对美国国立神经疾病与中风研究所组织型纤溶酶原激活剂治疗急性缺血性中风试验的重新分析结果。
Stroke. 2004 Oct;35(10):2418-24. doi: 10.1161/01.STR.0000140891.70547.56. Epub 2004 Sep 2.
8
Tissue plasminogen activator for acute ischemic stroke.用于急性缺血性卒中的组织型纤溶酶原激活剂
N Engl J Med. 1995 Dec 14;333(24):1581-7. doi: 10.1056/NEJM199512143332401.
Zotero 插件